These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11920394)

  • 1. Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.
    Oates JC; Reilly CM; Crosby MB; Gilkeson GS
    Arthritis Rheum; 2002 Mar; 46(3):598-605. PubMed ID: 11920394
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation.
    Kielian T; Drew PD
    J Neurosci Res; 2003 Feb; 71(3):315-25. PubMed ID: 12526021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.
    Sheu MY; Fowler AJ; Kao J; Schmuth M; Schoonjans K; Auwerx J; Fluhr JW; Man MQ; Elias PM; Feingold KR
    J Invest Dermatol; 2002 Jan; 118(1):94-101. PubMed ID: 11851881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation.
    Ueki S; Matsuwaki Y; Kayaba H; Oyamada H; Kanda A; Usami A; Saito N; Chihara J
    Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():30-6. PubMed ID: 15166481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease.
    Landreth GE; Heneka MT
    Neurobiol Aging; 2001; 22(6):937-44. PubMed ID: 11755002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-alpha and the pleiotropic responses to peroxisome proliferators.
    Tugwood JD; Aldridge TC; Lambe KG; Macdonald N; Woodyatt NJ
    Arch Toxicol Suppl; 1998; 20():377-86. PubMed ID: 9442309
    [No Abstract]   [Full Text] [Related]  

  • 7. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
    Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
    J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
    Henke BR
    J Med Chem; 2004 Aug; 47(17):4118-27. PubMed ID: 15293980
    [No Abstract]   [Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease.
    Hsueh WA; Bruemmer D
    Hypertension; 2004 Feb; 43(2):297-305. PubMed ID: 14732733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease].
    Dubuquoy L; Bourdon C; Peuchmaur M; Leibowitz MD; Nutten S; Colombel JF; Auwerx J; Desreumaux P
    Gastroenterol Clin Biol; 2000; 24(8-9):719-24. PubMed ID: 11011247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect.
    Trifilieff A; Bench A; Hanley M; Bayley D; Campbell E; Whittaker P
    Br J Pharmacol; 2003 May; 139(1):163-71. PubMed ID: 12746235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes.
    Moller DE; Greene DA
    Adv Protein Chem; 2001; 56():181-212. PubMed ID: 11329854
    [No Abstract]   [Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications.
    Chinetti G; Fruchart JC; Staels B
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S41-5. PubMed ID: 14704743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
    Plutzky J
    Am J Cardiol; 2003 Aug; 92(4A):34J-41J. PubMed ID: 12957325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eigenvalue analysis of peroxisome proliferator-activated receptor gamma agonists.
    Liao C; Xie A; Shi L; Zhou J; Lu X
    J Chem Inf Comput Sci; 2004; 44(1):230-8. PubMed ID: 14741032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.
    Willson TM; Cobb JE; Cowan DJ; Wiethe RW; Correa ID; Prakash SR; Beck KD; Moore LB; Kliewer SA; Lehmann JM
    J Med Chem; 1996 Feb; 39(3):665-8. PubMed ID: 8576907
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?
    Auwerx J
    Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G581-5. PubMed ID: 11897616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache.
    Rosen ED; Spiegelman BM
    J Clin Invest; 2000 Sep; 106(5):629-31. PubMed ID: 10974014
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease.
    Feinstein DL
    Diabetes Technol Ther; 2003; 5(1):67-73. PubMed ID: 12725709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.